If you're wondering about Vaxzevria, you’re not alone. It’s the brand name for the AstraZeneca COVID-19 vaccine used in many countries around the world, including South Africa. This vaccine plays a key role in protecting people against severe COVID-19 by teaching your body how to fight the virus.
So, how does Vaxzevria work? It uses a harmless virus to deliver instructions to your immune system, teaching it to recognize and defend against the coronavirus. This means if you catch COVID-19 later, your body can respond faster and keep you safer.
Vaxzevria is mainly given to adults but availability and recommendations can vary by country and age group. It’s usually administered in two doses spaced several weeks apart. Side effects are generally mild and short-lived—things like a sore arm, slight fever, or tiredness are normal and show your body is building protection.
Lots of people feel unsure about vaccine safety. The truth is health authorities keep a close eye on any side effects and the vaccine’s benefits in preventing serious illness far outweigh the risks. If you have specific health concerns, it’s worth chatting with your healthcare provider to get advice tailored for you.
After each dose, some folks notice temporary side effects such as headache or mild chills. These symptoms usually clear up in a day or two. Remember, experiencing no side effects doesn’t mean the vaccine isn't working. It simply varies from person to person.
Vaxzevria isn’t a magic shield but it greatly lowers your chances of ending up seriously ill or hospitalized. It also helps reduce virus spread, protecting your family and community. Taking the vaccine is a practical step that complements wearing masks and social distancing to keep life moving safely.
In short, Vaxzevria helps your body prepare for COVID-19’s worst effects. Staying informed about how it works and what to expect can ease worries and boost confidence in your choice to get vaccinated. Want to know more about vaccination sites or updates? Check local health resources or trusted news outlets like Cape Town Daily Buzz for daily coverage tailored to your area.
AstraZeneca has announced the discontinuation of its COVID-19 vaccine, Vaxzevria, developed with Oxford University, due to a significant drop in global demand. This decision follows the European Medicines Agency's withdrawal of the vaccine's marketing authorization at AstraZeneca's request.